Literature DB >> 23489706

Interactions among pro-inflammatory cytokines, IGF system and thyroid function in pre-pubertal obese subjects.

M E Street, A Smerieri, L Montanini, B Predieri, L Iughetti, M Valenzise, F De Luca, M Vigone, G Weber, M Maghnie, S Bernasconi.   

Abstract

Obesity is a state of chronic inflammation. Data on IGF system are often discrepant, and their relationships with mediators of inflammation are unknown. Furthermore, changes in thyroid function have been reported. We aimed at investigating the changes in these systems, and verify any relationships among cytokines, IGF system, thyroid function and insulin-insensitivity. Fifty obese pre-pubertal children, and 55 normal-weight subjects comparable for age and sex were enrolled. Serum IGF-I, IGF-II, IGFBP-1, IGFBP-2, IGFBP-3, IL-6 and TNF-alpha were assayed. In obese children insulin, TSH and FT4 were measured also, and the HOMA-IR index was calculated. Increased IGF-II, IL-6 and TNF-alpha, and decreased IGFBP-1 and IGFBP-2 concentrations were found in obese compared to normal-weight children. The IGF-I/IGFBP-3 molar ratio was also reduced in the obese subjects. In the obese children with high HOMA-IR index, IGFBP-1 and -2 serum concentrations were significantly decreased compared with those with normal insulin sensitivity, and in the obese subjects with increased TSH, IGFBP-2 concentrations were lower, and IGFBP-3 levels were higher compared to their counterparts with normal TSH levels. Among the significant correlations, BMISDS was correlated with IGF-II, and TSH. IGF-II concentrations showed a positive relationship with IL-6. TSH was correlated with IGFBP-2 also. The data showed interactions among IL-6, IGF system, insulin sensitivity, and thyroid function with changes being related to the degree of obesity. Chronic inflammation in obese children was confirmed. Some of the changes in the IGF system could be a consequence of insulin resistance and could account also for later complications in obese subjects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23489706

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  10 in total

1.  IGFBP-2 - taking the lead in growth, metabolism and cancer.

Authors:  Steven W Yau; Walid J Azar; Matthew A Sabin; George A Werther; Vincenzo C Russo
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

2.  Fasting Serum IGFBP-1 as a Marker of Insulin Resistance in Diverse School Age Groups.

Authors:  Amrit Bhangoo; Rishi Gupta; Steve P Shelov; Dennis E Carey; Siham Accacha; Ilene Fennoy; Lisa Altshuler; Barbara Lowell; Robert Rapaport; Warren Rosenfeld; Phyllis W Speiser; Svetlana Ten; Michael Rosenbaum
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-02       Impact factor: 6.055

3.  Modifications of IGF2 and EGFR plasma protein concentrations in NAFLD patients after bariatric surgery.

Authors:  Silvia Palmisano; Natalia Rosso; Pablo J Giraudi; Michela Giuricin; Deborah Bonazza; Nicolò de Manzini; Claudio Tiribelli
Journal:  Int J Obes (Lond)       Date:  2020-09-17       Impact factor: 5.095

4.  Whole-body and hepatic insulin resistance in obese children.

Authors:  Lorena del Rocío Ibarra-Reynoso; Liudmila Pisarchyk; Elva Leticia Pérez-Luque; Ma Eugenia Garay-Sevilla; Juan Manuel Malacara
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

5.  Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes.

Authors:  Melissa K Thomas; Amir Nikooienejad; Ross Bray; Xuewei Cui; Jonathan Wilson; Kevin Duffin; Zvonko Milicevic; Axel Haupt; Deborah A Robins
Journal:  J Clin Endocrinol Metab       Date:  2021-01-23       Impact factor: 5.958

6.  The Influence of Maternal Obesity and Breastfeeding on Infant Appetite- and Growth-Related Hormone Concentrations: The SKOT Cohort Studies.

Authors:  Anni Larnkjær; Ken K Ong; Emma M Carlsen; Katrine T Ejlerskov; Christian Mølgaard; Kim F Michaelsen
Journal:  Horm Res Paediatr       Date:  2018-06-29       Impact factor: 2.852

7.  Methylation and Expression of FTO and PLAG1 Genes in Childhood Obesity: Insight into Anthropometric Parameters and Glucose-Lipid Metabolism.

Authors:  Wojciech Czogała; Małgorzata Czogała; Wojciech Strojny; Gracjan Wątor; Paweł Wołkow; Małgorzata Wójcik; Mirosław Bik Multanowski; Przemysław Tomasik; Andrzej Wędrychowicz; Wojciech Kowalczyk; Karol Miklusiak; Agnieszka Łazarczyk; Przemysław Hałubiec; Szymon Skoczeń
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

Review 8.  The Insulin-Like Growth Factor System in Obesity, Insulin Resistance and Type 2 Diabetes Mellitus.

Authors:  Moira S Lewitt; Mairi S Dent; Kerstin Hall
Journal:  J Clin Med       Date:  2014-12-22       Impact factor: 4.241

9.  Thyroid Function and Thyroid Autoimmunity in Relation to Weight Status and Cardiovascular Risk Factors in Children and Adolescents: A Population-Based Study.

Authors:  Emilio García-García; María A Vázquez-López; Eduardo García-Fuentes; Rafael Galera-Martínez; Carolina Gutiérrez-Repiso; Icíar García-Escobar; Antonio Bonillo-Perales
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-01-18

10.  Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice.

Authors:  Anne Kammel; Sophie Saussenthaler; Markus Jähnert; Wenke Jonas; Laura Stirm; Andreas Hoeflich; Harald Staiger; Andreas Fritsche; Hans-Ulrich Häring; Hans-Georg Joost; Annette Schürmann; Robert W Schwenk
Journal:  Hum Mol Genet       Date:  2016-04-28       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.